mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.02 |